David Spaight

David Spaight is currently Chairman at CellCarta Biosciences, Inc., Director at HistoGenex Holding NV since 2019, and Independent Director at Certara, Inc. since 2022.
Former positions include Chief Executive Officer at WIL Research Holding Co., Inc., Chairman & Chief Executive Officer at Charles River Laboratories Ashland LLC, Chairman at BioIVT LLC, Chairman at Association of Clinical Research Organizations, Executive Chairman at Accumen, Inc., Executive Chairman at Oncology Analytics, Inc., Vice President-Global Sales & Marketing at Revvity, Inc. in 2005, President at MDS Pharma Services (Canada), Vice President-Global Sales & Marketing at Fisher Scientific Canada, and Vice President at PerkinElmer U.S.
LLC.
Education includes undergraduate and MBA degrees from the University of Michigan.